Detroit, MINCT07436078Now EnrollingIRB Ready

Female Breast Cancer Clinical Trial in Detroit, MI

Access cutting-edge female breast cancer treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.

Sponsored by Barbara Ann Karmanos Cancer Institute

Quick Self-Assessment

See if you qualify for this Detroit location

Preparing your pre-screening questions…

Expert Care in Detroit

Access female breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related female breast cancer treatment provided free

Apply for This Detroit Location

Check if you qualify for this female breast cancer clinical trial in Detroit, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Detroit

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Detroit site if eligible
  4. 4Begin participation

About This Female Breast Cancer Study in Detroit

The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investigators will: * adapt and refine a culturally relevant online educational genetic counseling program for at-risk African Americans * Test the effects of the educational program * collaborate with community leaders and clinical genetic professionals to translate study findings, develop a road map for dissemination to the community, and identify barriers to prepare for future trials. Participants from Detroit Research on Cancer Survivor group will be offered enrollment. Once consent is obtained, questionnaires will be completed before an online genetic counselling intervention immediately after, and at 3 months

Sponsor: Barbara Ann Karmanos Cancer Institute

Who Can Participate

Inclusion Criteria

Participants enrolled in Detroit Research on Cancer Survivors (Detroit ROCS)
Diagnosis of Primary Breast, prostate, or colorectal cancer on or after 1/1/2013
have received or currently receiving care at Karmanos Cancer Institute
meet one or more of the National Comprehensive Cancer Network (NCCN) guidelines for cancer genetic testing as described below Female breast
personal diagnosis at age ≤50
personal history of the triple-negative subtype
at least 1 close (first- or second-degree) relative diagnosed with breast cancer at age \<50
at least 1 close relative diagnosed with ovarian cancer
2+ close relatives diagnosed with breast or prostate cancer
age \<50 AND another primary breast cancer at any age
2+ primary breast cancers at any age OR Prostate
personal history of high-risk or very high-risk prostate cancer
personal history of regional or metastatic prostate cancer
personal history of less than high-risk prostate cancer with a suggestive family history (i.e., father or brother or multiple relatives with prostate cancer diagnosed at age \<60; at least 1 relative with breast, ovarian, or pancreatic cancer; or at least 1 relative with colorectal, ovarian, pancreatic, or kidney cancer) OR Colorectal
personal diagnosis at age ≤50
at least 1 close relative diagnosed with HNPCC at age \<50
at least 2 close relatives diagnosed with an HNPCC cancer at any age
colorectal and \>=1 primary endometrial, ovarian, gastric, pancreatic, or prostate

Exclusion Criteria

Previous genetic counseling and/or testing

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Detroit?

Yes, this clinical trial (NCT07436078) has an active research site in Detroit, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Female Breast Cancer Treatment Options in Detroit, MI

If you're searching for female breast cancer treatment options in Detroit, MI, this clinical trial (NCT07436078) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced female breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all female breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Detroit, MI

See all breast cancer clinical trials recruiting in Detroit — not just this study.

Browse Breast Cancer Trials in Detroit

Ready to Join in Detroit?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Detroit, MI